Upcoming FEBS Open Bio Webinar: Gangliosides and their Involvement in Diseases

We are very pleased to announce an upcoming free FEBS Open Bio webinar, which will be held on Zoom on 21st February 2024 at 16:00 CET (15:00 GMT). Prof. Sandro Sonnino will discuss the involvement of gangliosides in diseases associated with incorrectly organised membranes.
Upcoming FEBS Open Bio Webinar: Gangliosides and their Involvement in Diseases
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Update! Watch a recording of this talk.

To tie in with our recent special issue on the involvement of glycosphingolipids in diseases, FEBS Open Bio is holding a free webinar entitled "Gangliosides and their Involvement in Diseases Associated with Membranes with Incorrect Organization" on 21st February at 16:00 CET (15:00 GMT) for 45 minutes. Professor Sandro Sonnino (University of Milan) will discuss the involvement of gangliosides in pathologies associated with incorrectly organised membranes. For many years, glycosphingolipids were considered structural components of our membranes, but it subsequently became clear that glycosphingolipids, and particularly gangliosides, are necessary for the activity of membrane receptors and membrane enzymes. Gangliosides work as a starting switch for the transduction of information through the plasma membrane or for the initiation of functional processes and are associated with several pathologies.

We invite all researchers to attend what promises to be a fascinating webinar. Questions can be during the webinar, and we also invite attendees to send questions to the speakers in advance by sending them by email to [email protected]

Please register for free at the link here.

Join the FEBS Network today

Joining the FEBS Network’s molecular life sciences community enables you to access special content on the site, present your profile, 'follow' contributors, 'comment' on and 'like' content, post your own content, and set up a tailored email digest for updates.